Antares Pharma Profit Margin 2006-2019 | ATRS
Current and historical gross margin, operating margin and net profit margin for Antares Pharma (ATRS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Antares Pharma net profit margin as of June 30, 2019 is -4.03%.
|Antares Pharma Annual Profit Margins
|Antares Pharma Quarterly Profit Margins
||Medical & Dental Supplies
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.